Total
0
Shares
Lobe Sciences (CSE:LOBE) to presenting at the Emerging Growth Conference
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Lobe Sciences (LOBE) to present at the Emerging Growth Conference on April 14
  • Lobe will be presenting at 10:30 am Eastern time for 45 minutes
  • Lobe invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference
  • An archived webcast will also be made available on Emerging Growths website after the live event
  • Lobe Sciences Ltd. (LOBE) is up 3.33 per cent and is trading at C$0.16 per share at 11:12 am ET.

Lobe Sciences Ltd (LOBE) is pleased to announce that it has been invited to present at the Emerging Growth Conference on April 14.

This live, interactive online event will allow existing shareholders and the investment community to interact with Lobe's CEO and Director, Philip Young in real time.

Lobe will be presenting at 10:30 am Eastern time for 45 minutes.

The Emerging Growth conference is a way for public companies to present and communicate their new products, services, and other major announcements to the investment community from their office's convenience in a time-efficient manner.

Philip Young will provide a full presentation and will be available for questions after his presentation.

An archived webcast will also be made available on Emerging Growths website after the live event.

The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth.

Its audience includes potentially tens of thousands of individual and institutional investors, investment advisors, and analysts.

All sessions will be conducted through video webcasts and will take place in the Eastern time zone.

Lobe is a life sciences company focused on psychedelic medicines.

Lobe Sciences Ltd. (LOBE) is up 3.33 per cent and is trading at C$0.16 per share at 11:12 am ET.

More From The Market Herald
Clearmind Medicine (CSE:CMND) announces closing of private placement

" Clearmind Medicine (CSE:CMND) partners with The Hebrew University

Clearmind Medicine (CMND) has established a research and development partnership with the Yissum Research Development Company.
Small Pharma - CEO, Peter Rands (third from left) and the Small Pharma team. - The Market Herald Canada

" Negev Capital doubles down on Small Pharma (TSXV:DMT)

Negev Capital, a psychedelic medical intervention fund, has doubled its investment in Small Pharma (DMT).
PharmaTher (CSE:PHRM) added to the North American Psychedelics Index & the Horizons Psychedelic Stock Index ETF

" PharmaTher (CSE:PHRM) added to the North American Psychedelics Index & the Horizons Psychedelic Stock Index ETF

PharmaTher Holdings (PHRM) has been included in the North American Psychedelics Index.
Silo Wellness (CSE:SILO) debuts Marley One in collaboration with the Bob Marley family

" Psyched Wellness (CSE:PSYC) initiates a clinical sleep study

Psyched Wellness (PSYC) has initiated a clinical study of its AME-1 as a sleep-enhancing food supplement for self-declared insomniacs.